GlassScriptPhysician profile
Adrienne S Topic
NPI 1194068064
$9,150.90
in general payments reported to CMS, 2019-2025
28 companies · $2,342 in 2025
The $2,342 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,780 · 2020: $899 · 2021: $273 · 2022: $511 · 2023: $777 · 2024: $570 · 2025: $2,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242 · Travel and Lodging: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,242.45 |
| Travel and Lodging | $1,446.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,274.27 | 2019-2023 | Synergy |
| Penumbra, INC. | $1,875.11 | 2025 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $846.05 | 2019-2024 | Eliquis |
| Abiomed | $445.54 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $410.29 | 2021-2024 | Xarelto |
| Shockwave Medical, INC | $396.74 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $371.12 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $338.46 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $286.41 | 2019-2025 | Lifevest |
| Teleflex LLC | $260.40 | 2023-2025 | Guideliner, Turnpike |
| Novartis Pharmaceuticals Corporation | $206.38 | 2019-2025 | |
| Abbott Laboratories | $187.04 | 2019-2025 | Diamondback Coronary, Cardiomems, Assurity |
| Astrazeneca Pharmaceuticals LP | $169.55 | 2019-2025 | Lokelma |
| Medtronic, INC. | $153.09 | 2021-2024 | Onyx Frontier |
| Daiichi Sankyo INC. | $151.84 | 2023-2024 | Injectafer |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.82 | 2021-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $106.47 | 2019-2022 | |
| Chiesi USA, INC. | $91.87 | 2020-2022 | |
| Cardinal Health 200 LLC | $91.78 | 2019 | |
| Cook Medical LLC | $77.48 | 2019 | |
| Philips North America LLC | $62.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $50.10 | 2019 | |
| Pfizer INC. | $47.49 | 2020-2024 | |
| Sanofi-Aventis U.S. LLC | $36.26 | 2019-2020 | |
| Davol INC. | $32.15 | 2024 | Arista Ah Flexitip |
| Impulse Dynamics (USA) INC. | $26.47 | 2022 | |
| Terumo Medical Corporation | $17.51 | 2023 | Glidesheath Slender |
| Amarin Pharma, INC. | $16.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Topic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.